Our People

Ludwig Cancer Research is a community of the world's leading scientists, all pursuing innovative ways to prevent and control cancer. The Ludwig Institute for Cancer Research has an expansive research presence through its branches and collaborative laboratories around the world. In addition, the Ludwig Centers are scientific partners operating independently at six elite U.S. institutions. Learn more.

Jonathan C.A. Skipper, Executive Vice President for Technology Development, Ludwig Institute for Cancer Research
Skipper, PhD
Executive Vice President for Technology Development

I run technology development at the Ludwig Institute, a program that supports all aspects of scientific, clinical and business development required to build additional validation into Ludwig’s scientific discoveries. Enhancing or de-risking Ludwig’s inventions in this way leads to greater opportunities for partnership and ultimately ensures further development of our most promising technologies. Establishing collaborative and licensing relationships with not-for-profit or commercial partners is a critical process in moving Ludwig technologies into the clinic where they might benefit cancer patients. I have completed numerous partnering transactions with biopharma companies, including several Ludwig start-up biotechnology companies that I have been instrumental in establishing, to develop different Ludwig technologies. I received a PhD in Immunology from University College London and completed further research at the University of Virginia and the University of Oxford.